372 related articles for article (PubMed ID: 25589020)
1. Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery.
Iglesias P; Civantos S; Vega B; Pavón I; Guijarro G; Monereo S
Obes Surg; 2015 Mar; 25(3):575-8. PubMed ID: 25589020
[TBL] [Abstract][Full Text] [Related]
2. Effective weight loss after treatment with a glucagon-like peptide-1 receptor agonist in a morbidly obese and diabetic patient before bariatric surgery: a case report.
Chen JH; Tang WH; Lee CH
J Med Case Rep; 2014 Sep; 8():304. PubMed ID: 25213589
[TBL] [Abstract][Full Text] [Related]
3. One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice.
Buysschaert M; Preumont V; Oriot PR; Paris I; Ponchon M; Scarnière D; Selvais P;
Diabetes Metab; 2010 Nov; 36(5):381-8. PubMed ID: 20598606
[TBL] [Abstract][Full Text] [Related]
4. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
Nestvold TK; Nielsen EW; Lappegård KT
Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF; Mannucci E; Ahrén B
Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
[TBL] [Abstract][Full Text] [Related]
8. Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials.
Su N; Li Y; Xu T; Li L; Kwong JS; Du H; Ren K; Li Q; Li J; Sun X; Li S; Tian H
Int J Cardiol; 2016 Sep; 219():293-300. PubMed ID: 27343423
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
Tzefos M; Harris K; Brackett A
Ann Pharmacother; 2012 Jan; 46(1):68-78. PubMed ID: 22232377
[TBL] [Abstract][Full Text] [Related]
10. Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes.
Tokuda M; Katsuno T; Ochi F; Miyakoshi K; Kusunoki Y; Murai K; Miuchi M; Hamaguchi T; Miyagawa J; Namba M
Endocr J; 2014; 61(4):365-72. PubMed ID: 24452017
[TBL] [Abstract][Full Text] [Related]
11. Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
Ishøy PL; Knop FK; Broberg BV; Bak N; Andersen UB; Jørgensen NR; Holst JJ; Glenthøj BY; Ebdrup BH
Diabetes Obes Metab; 2017 Feb; 19(2):162-171. PubMed ID: 27717222
[TBL] [Abstract][Full Text] [Related]
12. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
Liu J; Hu Y; Zhang H; Xu Y; Wang G
J Diabetes Complications; 2016; 30(8):1555-1559. PubMed ID: 27503404
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
Iványi T; Fövényi J; Faludi P; Han J; Macconell L; Wille S; Kiljanski J
Clin Ther; 2012 Jun; 34(6):1301-13. PubMed ID: 22608106
[TBL] [Abstract][Full Text] [Related]
14. Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.
Horton ES; Silberman C; Davis KL; Berria R
Diabetes Care; 2010 Aug; 33(8):1759-65. PubMed ID: 20460445
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
Cuthbertson DJ; Irwin A; Gardner CJ; Daousi C; Purewal T; Furlong N; Goenka N; Thomas EL; Adams VL; Pushpakom SP; Pirmohamed M; Kemp GJ
PLoS One; 2012; 7(12):e50117. PubMed ID: 23236362
[TBL] [Abstract][Full Text] [Related]
16. Remission of insulin resistance in type 2 diabetic patients after gastric bypass surgery or exenatide therapy.
Yong W; Shibo W; Jingang L
Obes Surg; 2012 Jul; 22(7):1060-7. PubMed ID: 22441815
[TBL] [Abstract][Full Text] [Related]
17. Improved glycemic control and reduction of cardiometabolic risk factors in subjects with type 2 diabetes and metabolic syndrome treated with exenatide in a clinical practice setting.
Bhushan R; Elkind-Hirsch KE; Bhushan M; Butler WJ; Duncan K; Marrioneaux O
Diabetes Technol Ther; 2009 Jun; 11(6):353-9. PubMed ID: 19459763
[TBL] [Abstract][Full Text] [Related]
18. Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.
Pujante P; Hellín MD; Fornovi A; Martínez Camblor P; Ferrer M; García-Zafra V; Hernández AM; Frutos MD; Luján-Monpeán J; Tébar J
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):812-8. PubMed ID: 24773862
[TBL] [Abstract][Full Text] [Related]
19. Add on Exenatide Treatment is Beneficial in Poorly Controlled Obese Type 2 Diabetics under Intensive Insulin Regimens.
Sönmez A; Dinç M; Taşlıpınar A; Aydoğdu A; Meriç C; Başaran Y; Haymana C; Demir O; Yılmaz İ; Azal Ö
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):256-261. PubMed ID: 28201828
[No Abstract] [Full Text] [Related]
20. Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation.
Cotugno M; Nosso G; Saldalamacchia G; Vitagliano G; Griffo E; Lupoli R; Angrisani L; Riccardi G; Capaldo B
Acta Diabetol; 2015 Apr; 52(2):331-6. PubMed ID: 25218924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
